Last updated: October 13, 2022
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lung Cancer
Lung Disease
Surgery
Treatment
N/AClinical Study ID
NCT05583916
2021-7318
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Signed or verbal informed consent by participant
- Male and female adults, age 18 and above
- Clinical stage I-II lung cancer (suspected, proven, unproven), or secondary pulmonarymalignancy
- BMI < 35
- ECOG 0-1
- Eligible for surgery and lung cancer resection (FEV1 > 60%, DLCO > 60%)
- Elective VATS anatomic resection (segmentectomy or lobectomy), or wedge resection
- Capable caregiver for discharge home
Exclusion
Exclusion Criteria:
- Clinical stage III lung cancer
- Surgery requiring pneumonectomy
- Neoadjuvant therapy
- Active pregnancy or breastfeeding
- History of chronic pain syndromes
- History of chronic opioid use
- Concomitant major surgery indicated with current admission to hospital
- Anticipated intraoperative complication including conversion to thoracotomy, majorbleeding requiring blood transfusion, extensive adhesiolysis, injury to mediastinalstructures, airway injury, nerve injury (phrenic, recurrent)
- Need for epidural or patient-controlled intravenous analgesia
- Need for urinary catheter
Study Design
Total Participants: 20
Study Start date:
September 07, 2022
Estimated Completion Date:
October 31, 2023
Connect with a study center
McGill University Health Centre
Montreal, Quebec H4A 3J1
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.